Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia

Involuntary Movements Following Administration of Hydroxychloroquine for COVID-19 Pneumonia

Hydroxychloroquine (HCQ) has been used as an investigational drug for patients with moderate to severe coronavirus disease 2019 (COVID-19). There have been concerns of potential harms from side effects of the drug. We present a case of a 38-year-old male who was started on HCQ for COVID-19 pneumonia...

Full description

Bibliographic Details
Main Authors: Emmaline Zantua Fernando, Jeryl Ritzi Tan Yu, Salvador Miclat Abad Santos, Roland Dominic Go Jamora
Format: Article
Language:English
Published: Korean Movement Disorder Society 2021-01-01
Series:Journal of Movement Disorders
Subjects:
adverse drug reactions
covid-19
hydroxychloroquine
involuntary movements
myoclonus
tremors
Online Access:http://www.e-jmd.org/upload/jmd-20091.pdf

Internet

http://www.e-jmd.org/upload/jmd-20091.pdf

Similar Items